Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' on the webpage has recently changed to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change likely reflects updates in the medical and healthcare-related criteria for individuals participating in the clinical research study.
    Difference
    60%
    Check dated 2024-05-22T08:12:01.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    16 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . This change likely indicates an update or revision in the estimated completion date for the clinical trial involving Nivolumab, Bevacizumab, and Rucaparib as a treatment for relapsed Ovarian, Fallopian Tube, or Peritoneal Cancer.
    Difference
    0.0%
    Check dated 2024-05-09T01:59:03.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage related to a Phase II study of Nivolumab, Bevacizumab, and Rucaparib for the treatment of Relapsed Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer has been updated with new estimated completion dates and additional information about the FDA approvals of the drugs involved.
    Difference
    1.0%
    Check dated 2024-05-07T19:59:14.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:26:16.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.